RecruitingNot ApplicableNCT06454734

Shock Wave Therapy for Lower Limb Lymphedema

Lower Limb Lymphedema Treatment by Extracorporeal Shock Wave Therapy: Clinical Trial

Sponsor

Parc de Salut Mar

Enrollment

30 participants

Start Date

May 28, 2024

Study Type

INTERVENTIONAL

Conditions

Lymphedema, Lower Limb

Summary

This is a double-blind randomized clinical trial to compare the effect of shock wave therapy on lower limb lymphedema. There are two arms: A) complex decongestive therapy + extracorporeal shock waves therapy; B) complex decongestive therapy plus placebo extracorporeal shock waves.

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying DLT, Extracorporeal shock wave therapy by radial device, and others for people with lymphedema, lower limb. The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEExtracorporeal shock wave therapy by radial device

Patients will receive treatment by extracorporeal shock waves therapy (ESWT).

DEVICEPlacebo extracorporeal shock wave therapy by radial device

Patients will receive treatment sham extracorporeal shock waves.

OTHERDLT

Patients will receive treatment with decongestive lymphatic therapy (DLT: manual lymphatic drainage, compression)

Locations(1)

Hospital del Mar

Barcelona, Spain

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06454734

Related Trials

The N-LVA Study: RCT Comparing LVA vs. Sham Surgery in Cancer-related Lymphedema

NCT060823493 locations